2026 Q1 -tulosraportti
Vain PDF
11 päivää sitten
Tarjoustasot
First North Denmark
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 500 | - | - | ||
| 342 | - | - | ||
| 2 752 | - | - | ||
| 3 689 | - | - | ||
| 400 | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 47 415 | 47 415 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 47 415 | 47 415 | 0 | 0 |
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 20.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 7.5. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 22.10.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 | ||
2025 Q1 -tulosraportti 8.5.2025 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
·19 t sittenHave bought x-number when They came on the market (listed on the stock exchange), saw it as a sensible business for the investment, as the market is there. The company has not been able to live up to that. Someone has made money.! All other companies within the industry can make money, generate value. So should I sell and take a big loss, or bet on the adults being able to achieve growth in the future .?
·4 t sittenIf you sell and buy again, you get a deduction on the loss, which is deducted from the profit. But if it's because you're in doubt whether you should stay in the stock, then you can read below about the considerations I have about this stock. You've been involved longer than I have, and therefore you have a backpack full of disappointments and broken promises, (I've read that) I only got into Stenocare when they had completely phased out production. I can only say that they have put extra oomph into the promotion of Astrum10-10 oil after the oil has received all the advantages one can get in Germany if the medicine is to become a sales success there. The four advantages: It is approved by the two largest insurance companies. It has 100 % reimbursement It has received fast track status and last but not least, that the oil resembles the medicine that doctors are trained to use. The four advantages remove all doctors' fear of prescribing Astrum10-10, so these advantages are the reason why Stenocare's management and analysts agree that Astrum 10-10 will become very valuable for Stenocare. Since I am annoyed that Stenocare's management has decided that they want to own the narrative, and thus will not answer questions from us shareholders, I have found an alternative way for us to follow whether Weeco gets doctors to prescribe more prescriptions or not, which I do by following approx 15 online pharmacies in Germany, and seeing if more or fewer have the oil in stock. I write about this on Nordnet social. The risk with this stock will be, or the fly in the ointment will be, that Stenocare's target 0,3 does not deliver, but so far they are following the plan. this is the latest analysis I could find. https://analystgroup.se/kommentarer/comment-on-stenocares-q4-report-2025/- ·2 päivää sittenstock status Bonus info: There are 319 who have given Astrum oil 4.9 stars, on average, in Düsseldorf. new Canngo: in stock green. CannabisApo24 : from green to red (sold out )·1 t sittenI have an open account, so you can go in and see for yourself. 1,57 kr. I bought the first time when it was at 2 kr. something, and then I have bought more continuously, after Astrum 10-10 has received the 4 advantages, which I have described several times by now. If you scroll down I have written in detail why these 4 advantages have removed the fear of prescribing Astrum10-10 at doctors in Germany
- ·14.5.Stock status Stenocare first registers the sale in Germany, in their accounts, when the end-user redeems the prescription at the Pharmacy. New CannabisApo24 in stock green dot Is an online pharmacy and is nationwide, but has a physical pharmacy in Augsburg Stock status is status quo, for the others from yesterday. It is closed today in Germany
- ·13.5.stock status. For information. Germany is still running on the old system, where staff, manually, order from Weeco, to replenish goods, so we must expect periods of sold-out items. (Most stores in Denmark, the cash register also functions as inventory logistics. Therefore, empty shelves are rare) Flowzs: yesterday none of their customers had oil in stock. Today two pharmacies have become retailers of the oil and the oil is a stock item. These are pharmacies in Düsseldorf and Tübingen. Grunhorn Leipzig: sold out, it was also sold out yesterday. It will be interesting if the oil comes back in stock. Cannabis Taxa, services all of Germany. The oil is an order item Medcan one stop: They have more than 400 pharmacies in their network. Green dot. The oil is a stock item, at two pharmacies, in Mannheim Cannabis pharmacy ( kõln) green dot unchanged Weed.de: green dot stock item 2 pharmacies unchanged from yesterday They do not state where these are located
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2026 Q1 -tulosraportti
Vain PDF
11 päivää sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·19 t sittenHave bought x-number when They came on the market (listed on the stock exchange), saw it as a sensible business for the investment, as the market is there. The company has not been able to live up to that. Someone has made money.! All other companies within the industry can make money, generate value. So should I sell and take a big loss, or bet on the adults being able to achieve growth in the future .?·4 t sittenIf you sell and buy again, you get a deduction on the loss, which is deducted from the profit. But if it's because you're in doubt whether you should stay in the stock, then you can read below about the considerations I have about this stock. You've been involved longer than I have, and therefore you have a backpack full of disappointments and broken promises, (I've read that) I only got into Stenocare when they had completely phased out production. I can only say that they have put extra oomph into the promotion of Astrum10-10 oil after the oil has received all the advantages one can get in Germany if the medicine is to become a sales success there. The four advantages: It is approved by the two largest insurance companies. It has 100 % reimbursement It has received fast track status and last but not least, that the oil resembles the medicine that doctors are trained to use. The four advantages remove all doctors' fear of prescribing Astrum10-10, so these advantages are the reason why Stenocare's management and analysts agree that Astrum 10-10 will become very valuable for Stenocare. Since I am annoyed that Stenocare's management has decided that they want to own the narrative, and thus will not answer questions from us shareholders, I have found an alternative way for us to follow whether Weeco gets doctors to prescribe more prescriptions or not, which I do by following approx 15 online pharmacies in Germany, and seeing if more or fewer have the oil in stock. I write about this on Nordnet social. The risk with this stock will be, or the fly in the ointment will be, that Stenocare's target 0,3 does not deliver, but so far they are following the plan. this is the latest analysis I could find. https://analystgroup.se/kommentarer/comment-on-stenocares-q4-report-2025/
- ·2 päivää sittenstock status Bonus info: There are 319 who have given Astrum oil 4.9 stars, on average, in Düsseldorf. new Canngo: in stock green. CannabisApo24 : from green to red (sold out )·1 t sittenI have an open account, so you can go in and see for yourself. 1,57 kr. I bought the first time when it was at 2 kr. something, and then I have bought more continuously, after Astrum 10-10 has received the 4 advantages, which I have described several times by now. If you scroll down I have written in detail why these 4 advantages have removed the fear of prescribing Astrum10-10 at doctors in Germany
- ·14.5.Stock status Stenocare first registers the sale in Germany, in their accounts, when the end-user redeems the prescription at the Pharmacy. New CannabisApo24 in stock green dot Is an online pharmacy and is nationwide, but has a physical pharmacy in Augsburg Stock status is status quo, for the others from yesterday. It is closed today in Germany
- ·13.5.stock status. For information. Germany is still running on the old system, where staff, manually, order from Weeco, to replenish goods, so we must expect periods of sold-out items. (Most stores in Denmark, the cash register also functions as inventory logistics. Therefore, empty shelves are rare) Flowzs: yesterday none of their customers had oil in stock. Today two pharmacies have become retailers of the oil and the oil is a stock item. These are pharmacies in Düsseldorf and Tübingen. Grunhorn Leipzig: sold out, it was also sold out yesterday. It will be interesting if the oil comes back in stock. Cannabis Taxa, services all of Germany. The oil is an order item Medcan one stop: They have more than 400 pharmacies in their network. Green dot. The oil is a stock item, at two pharmacies, in Mannheim Cannabis pharmacy ( kõln) green dot unchanged Weed.de: green dot stock item 2 pharmacies unchanged from yesterday They do not state where these are located
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
First North Denmark
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 500 | - | - | ||
| 342 | - | - | ||
| 2 752 | - | - | ||
| 3 689 | - | - | ||
| 400 | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 47 415 | 47 415 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 47 415 | 47 415 | 0 | 0 |
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 20.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 7.5. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 22.10.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 | ||
2025 Q1 -tulosraportti 8.5.2025 |
2026 Q1 -tulosraportti
Vain PDF
11 päivää sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 20.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 7.5. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 22.10.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 | ||
2025 Q1 -tulosraportti 8.5.2025 |
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·19 t sittenHave bought x-number when They came on the market (listed on the stock exchange), saw it as a sensible business for the investment, as the market is there. The company has not been able to live up to that. Someone has made money.! All other companies within the industry can make money, generate value. So should I sell and take a big loss, or bet on the adults being able to achieve growth in the future .?·4 t sittenIf you sell and buy again, you get a deduction on the loss, which is deducted from the profit. But if it's because you're in doubt whether you should stay in the stock, then you can read below about the considerations I have about this stock. You've been involved longer than I have, and therefore you have a backpack full of disappointments and broken promises, (I've read that) I only got into Stenocare when they had completely phased out production. I can only say that they have put extra oomph into the promotion of Astrum10-10 oil after the oil has received all the advantages one can get in Germany if the medicine is to become a sales success there. The four advantages: It is approved by the two largest insurance companies. It has 100 % reimbursement It has received fast track status and last but not least, that the oil resembles the medicine that doctors are trained to use. The four advantages remove all doctors' fear of prescribing Astrum10-10, so these advantages are the reason why Stenocare's management and analysts agree that Astrum 10-10 will become very valuable for Stenocare. Since I am annoyed that Stenocare's management has decided that they want to own the narrative, and thus will not answer questions from us shareholders, I have found an alternative way for us to follow whether Weeco gets doctors to prescribe more prescriptions or not, which I do by following approx 15 online pharmacies in Germany, and seeing if more or fewer have the oil in stock. I write about this on Nordnet social. The risk with this stock will be, or the fly in the ointment will be, that Stenocare's target 0,3 does not deliver, but so far they are following the plan. this is the latest analysis I could find. https://analystgroup.se/kommentarer/comment-on-stenocares-q4-report-2025/
- ·2 päivää sittenstock status Bonus info: There are 319 who have given Astrum oil 4.9 stars, on average, in Düsseldorf. new Canngo: in stock green. CannabisApo24 : from green to red (sold out )·1 t sittenI have an open account, so you can go in and see for yourself. 1,57 kr. I bought the first time when it was at 2 kr. something, and then I have bought more continuously, after Astrum 10-10 has received the 4 advantages, which I have described several times by now. If you scroll down I have written in detail why these 4 advantages have removed the fear of prescribing Astrum10-10 at doctors in Germany
- ·14.5.Stock status Stenocare first registers the sale in Germany, in their accounts, when the end-user redeems the prescription at the Pharmacy. New CannabisApo24 in stock green dot Is an online pharmacy and is nationwide, but has a physical pharmacy in Augsburg Stock status is status quo, for the others from yesterday. It is closed today in Germany
- ·13.5.stock status. For information. Germany is still running on the old system, where staff, manually, order from Weeco, to replenish goods, so we must expect periods of sold-out items. (Most stores in Denmark, the cash register also functions as inventory logistics. Therefore, empty shelves are rare) Flowzs: yesterday none of their customers had oil in stock. Today two pharmacies have become retailers of the oil and the oil is a stock item. These are pharmacies in Düsseldorf and Tübingen. Grunhorn Leipzig: sold out, it was also sold out yesterday. It will be interesting if the oil comes back in stock. Cannabis Taxa, services all of Germany. The oil is an order item Medcan one stop: They have more than 400 pharmacies in their network. Green dot. The oil is a stock item, at two pharmacies, in Mannheim Cannabis pharmacy ( kõln) green dot unchanged Weed.de: green dot stock item 2 pharmacies unchanged from yesterday They do not state where these are located
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
First North Denmark
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 500 | - | - | ||
| 342 | - | - | ||
| 2 752 | - | - | ||
| 3 689 | - | - | ||
| 400 | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 47 415 | 47 415 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 47 415 | 47 415 | 0 | 0 |